Udisense DBA Nanit
The goal of this clinical trial is to learn whether a smart baby monitor with full sleep analytics and behavioral guidance improves infant sleep and parent well-being in first-time parents during the first six months after birth. The main questions it aims to answer are: 1. Does access to Nanit's full monitoring features improve infant nighttime sleep - including total sleep time, bedtime consistency, nighttime awakenings, and how often parents need to intervene at night? 2. Does it improve sleep quality and mental health outcomes for parents, including reduced postpartum depression and anxiety symptoms? Researchers will compare families using the Nanit camera with full Milestone Insights features (sleep analytics, behavioral guidance, and developmental tracking) to families using the Nanit camera with live video only, to see whether the full suite of features leads to better sleep and well-being outcomes.
Inclusion Criteria: * Primary caregiver is biological parent * Expecting first child (nulliparous) * Currently between 34 weeks of gestation and end of gestation * Primary caregiver aged 21 or older * Access to a smartphone or tablet compatible with the Nanit application * Able to complete study surveys in English * Any family structure (single parent, coupled, same-sex couples, etc.) Exclusion Criteria: * Infant born prior to 35 weeks gestational age (preterm birth) * Infant born with a severe medical condition requiring intensive neonatal care at time of study measures * Multiple gestatio…
A smart baby monitor camera providing live video streaming combined with full access to sleep analytics, behavioral guidance notifications, developmental milestone tracking, and in-app parenting tips via the Nanit mobile application. Participants use the device as their primary infant monitor from birth through 6 months postpartum.
A smart baby monitor camera providing live video streaming only. Sleep analytics, behavioral guidance, developmental tracking, and in-app guidance features are disabled for the duration of the study. Participants use the device as their primary infant monitor from birth through 6 months postpartum.
Arctuva estimate
Verify or correct the compensation shown for this listing.